The use of hyperbaric oxygen therapy in head-and-neck conditions

• Published in: Journal of head & neck physicians and surgeons 2020-01, Vol.8 (1), p.27-33
• Main Authors: Nabil, Syed, Nordin, Rifqah, Hariri, Firdaus, Mohamad Bustaman, Ahmad, Syed Zainal, Sharifah, Panicker, Divya, Nazimi, Abdul
• Format: Article
• Language: English
• Subjects: bisphosphonate; flaps; head and neck; hyperbaric oxygen therapy; osteoradionecrosis
• ISSN: 2347-8128; 2347-8128
• DOI: 10.4103/jhnps.jhnps_16_20

Introduction: Hyperbaric oxygen therapy (HBOT) has been suggested to be beneficial in managing compromised acute and chronic wounds. To shed some light on its effectiveness in head-and-neck wounds, a retrospective review on the use of HBOT was done. Materials and Methods: The medical records of patients receiving HBOT for head-and-neck conditions were reviewed. The demographics and clinical data were collected. Results: Seventeen patients were identified. Four major indications for therapy were identified being osteoradionecrosis (ORN) treatment, ORN prophylaxis, treatment of compromised flaps/grafts, and treatment of medication-related osteonecrosis of the jaw. Favorable outcome following HBOT was seen in 77% of patients. In the treatment of ORN, 56% cases treated were successful. In the remaining groups, 100% success rates were obtained. The majority of patients had HBOT as an adjunctive treatment. HBOT as an adjunct was successful in 71% of patients, while prophylactic HBOT were successful in all patients. Complications including ear barotrauma and sinus squeeze were seen in 24% of patients. Conclusions: HBOT can be successfully used in various head-and-neck conditions, especially when used in cases with compromised flaps/graft or ORN prophylaxis. It is well tolerated and thus provides a valid adjunctive therapy in the management of tissue with compromised healing capability in the head-and-neck region.